Dr. Cynthia Verst is president, Design and Delivery Innovation, for the Research & Development Solutions organization at IQVIA. Previously, Cynthia served as president, Clinical Operations for the Research and Development Solutions organization. With more than 20 years of biopharmaceutical industry experience, Cynthia has a proven track record of operational excellence and innovation. Before being appointed president of Clinical Operations in 2015, Cynthia served as president of Real-World & Late Phase Research at Quintiles. In 2014, she was named one of the top women in biotech by FierceBiotech, an annual award that spotlights 15 female leaders in life sciences, academia, and regulatory roles. Cynthia currently sits on the Boards of Q2 Solutions, ACRO and DIA.
Prior to joining Quintiles, she served as senior vice president, Global Late Phase Research for OptumInsight (a division of UnitedHealth Group), where she and her team successfully established a new global Late Phase Research Business Unit. Cynthia began her career in biopharma at Procter & Gamble Pharmaceuticals as section head in its North American Medical and Technical Affairs group, successfully leading the Phase IIIB/IV research requirements of marketed products.
Cynthia holds a doctorate and bachelor’s degree in Pharmacy from the University of Cincinnati, a master’s degree in Structural and Cellular Biology from the University of Illinois, and bachelor’s degrees in Biology and Chemistry from Northern Kentucky University.